Colon Carcinoma | Topics

Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes

A study of over 229,000 obese adults without diabetes found that weight loss drugs, such as semaglutide and tirzepatide, were associated with a 41% decrease in the overall risk of developing obesity-related cancers. GLP-1 RAs also showed larger reductions in certain subgroups, including men and gynaecologic cancers.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeObservational study·DateJun 7, 2026

Blood test may help identify which colon cancer patients benefit from NSAIDs

A blood test may help doctors identify which patients with colon cancer can benefit from anti-inflammatory medication and chemotherapy after surgery. The test measures circulating tumor DNA levels, and high-risk patients who test positive see improved survival rates when taking celecoxib with chemotherapy.

SourceAlliance for Clinical Trials in Oncology·JournalJAMA Oncology·TypeRandomized controlled/clinical trial·DateDec 15, 2025

Development, validation of a deep learning algorithm to differentiate colon carcinoma from diverticulitis in CT images

A deep learning model distinguishes colon carcinoma from acute diverticulitis in CT images, improving diagnostic performance and reducing false-negative and false-positive findings. The model's sensitivity and specificity were significantly improved, supporting radiologists in patient care.

SourceJAMA Network·JournalJAMA Network Open·DateJan 27, 2023